Medical and Dental Consultants’ Association of Nigeria
Home - About us - Editorial board - Search - Ahead of print - Current issue - Archives - Submit article - Instructions - Subscribe - Advertise - Contacts - Login 
  Users Online: 1006   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
 

    Article Cited by others

REVIEW ARTICLE

Review of hormonal treatment of breast cancer

Abdulkareem I H, Zurmi I B

Year : 2012| Volume: 15| Issue : 1 | Page no: 9-14

   This article has been cited by
 
1 Beyond CTLA-4 and PD-1: Orphan nuclear receptor NR2F6 as T cell signaling switch and emerging target in cancer immunotherapy
Victoria Klepsch,Natascha Hermann-Kleiter,Gottfried Baier
Immunology Letters. 2016;
[Pubmed]  [Google Scholar] [DOI]
2 Benefits and Harms of Phytoestrogen Consumption in Breast Cancer Survivors
Sadaf Alipour,Shahrzad Jafari-Adli,Amirhossein Eskandari
Asian Pacific Journal of Cancer Prevention. 2015; 16(8): 3091
[Pubmed]  [Google Scholar] [DOI]
3 Antimitotic drugs in the treatment of cancer
Rustelle Janse van Vuuren,Michelle H. Visagie,Anne E. Theron,Annie M. Joubert
Cancer Chemotherapy and Pharmacology. 2015; 76(6): 1101
[Pubmed]  [Google Scholar] [DOI]
4 Metastatic breast cancer presenting as severe anemia, platelet reduction and abnormal cells in peripheral blood
Seisuke Ota,Akinori Kasahara,Shoma Mizuno,Haruka Fukatsu,Osamu Kinoshita,Toshio Noguchi,Nobuyasu Kishimoto,Tadashi Matsumura
Okayama Igakkai Zasshi (Journal of Okayama Medical Association). 2014; 126(1): 31
[Pubmed]  [Google Scholar] [DOI]
5 HER2/neu-positive and hormone receptor-positive breast cancers. Primary systemic treatment, sentinel node biopsy and hormone therapy [Cáncer de mama con Her-2-neu y receptores hormonales positivos. Tratamiento sistémico primario, biopsia del ganglio centinela y hormonoterapia]
Nayara López, C. and José Ignacio Sánchez, M. and Javier De Santiago, G.
Revista Chilena de Obstetricia y Ginecologia. 2013; 78(1): 44-47
[Pubmed]  [Google Scholar]
6 Acting on hormone receptors with minimal side effect on cell proliferation: A timely challenge illustrated with GLP-1R and GPER
Gigoux, V., Fourmy, D.
Frontiers in Endocrinology. 2013; 4(2013): 50
[Pubmed]  [Google Scholar]
7 Homocysteine as a Biomarker for Predicting Disease-Free Survival in Breast Cancer
Daniela Filippini Ierardi,Luis Gustavo Raimundo,Gimena Aguiar,Patrícia Bandeira Rueda Germano,Luiz Henrique Gebrim,Nelson Carvas,Bruno Frederico Aguilar Calegare,Vânia D’Almeida,Catarina Segreti Porto,Miriam Galvonas Jasiulionis,Mariangela Correa
Advances in Breast Cancer Research. 2013; 02(02): 24
[Pubmed]  [Google Scholar] [DOI]
8 Role of KLF5 in Hormonal Signaling and Breast Cancer Development
Liu, R. and Dong, J.-T. and Chen, C.
Vitamins and Hormones. 2013; 93: 213-225
[Pubmed]  [Google Scholar]
9 Steroid receptor coactivator-1: A versatile regulator and promising therapeutic target for breast cancer
Yanlei Zhang,Chenyang Duan,Chen Bian,Ying Xiong,Jiqiang Zhang
The Journal of Steroid Biochemistry and Molecular Biology. 2013; 138: 17
[Pubmed]  [Google Scholar] [DOI]
10 Breast cancer with Her-2-neu positive and hormone receptor. Neoadjuvant chemotherapy, sentinel node biopsy and hormonal treatment [Cáncer de mama con Her-2-neu y receptores hormonales positivos. Quimioterapia neoadyuvante, biopsia de ganglio centinela y tratamiento hormonal]
Carpintero, N.L. and MĂ©ndez, J.I.S. and GarcĂ­a, J.I.S.
Ginecologia y Obstetricia de Mexico. 2012; 80(11): 720-724
[Pubmed]  [Google Scholar]

 

Read this article